Clinical trial NCT06867640: Effects of Forgiveness-Based Group Psychoeducation Applied to Cancer Survivors
Official title: Effects of Forgiveness-Based Group Psychoeducation Applied to Cancer Survivors on Fear of Cancer Recurrence, Forgiveness, Quality of Life, and Psychiatric Symptoms: a Randomized Controlled Trial
Study type: INTERVENTIONAL
Overall status: ENROLLING_BY_INVITATION
Phase: NA
Conditions: Cancer Survivors
Keywords: Cancer Survivors
Forgiveness
Psychoeducation
Fear of Cancer Recurrence
Quality of Life
Psychiatric Symptoms
Lead sponsor: Lokman Hekim Üniversitesi
Sponsor class: OTHER_GOV
Collaborators: name: Saglik Bilimleri Universitesi
First posted: 2025-03-10
Enrollment: 60
Sex: ALL
Minimum age (years): 18
Standard ages: ADULT
OLDER_ADULT
Accepts healthy volunteers: no
Allocation: NA
Intervention model: PARALLEL
Intervention model description: Forgiveness-Based Group Psychoeducation
Primary purpose: OTHER

Brief summary: This study aims to examine the effects of forgiveness-based group psychoeducation applied to cancer survivors on fear of cancer recurrence, forgiveness, quality of life and psychiatric symptoms.

Detailed description: This study was designed as a randomized controlled experimental study with a pre-test-post-test and follow-up design to examine the effects of forgiveness-based group psychoeducation on fear of cancer recurrence, forgiveness, quality of life and psychiatric symptoms of cancer survivors.

The aim is to evaluate the effects of a forgiveness-based psychoeducation program on cancer survivors. After the "Informed Voluntary Consent Form" is obtained from individuals who agree to participate in the study, the Introductory Information Form, Heartland Forgiveness Scale, Fear of Relapse Inventory, EORTC QLQ-C30 Quality of Life Scale and Brief Symptom Inventory will be applied. Pre-tests will be applied to the sample determined by an independent statistician. Then, participants will be divided into intervention and control groups by simple randomization method. Face-to-face forgiveness-based psychoeducation will be applied to the intervention group in 90-minute sessions once/twice a week, totaling 6 sessions. In the last session of psychoeducation, a post-test ("Introductory Information Form", "Heartland Forgiveness Scale", "Fear of Relapse Inventory", "EORTC QLQ-C30 Quality of Life Scale" and "Brief Symptom Inventory") will be administered to both the intervention and control groups. The first follow-up test of the study will be administered to both the intervention and control groups 1 month after the post-test, and the second follow-up test of the study will be administered 3 months after the post-test. After the completion of the study and the measurements, it is planned to provide forgiveness-based psychoeducation to the participants in the control group.

Eligibility criteria: Inclusion Criteria:

* Written and verbal consent to participate in the study
* Understanding and speaking Turkish
* Being over 18 years old
* Not having any visual, hearing or mental disabilities
* Having been diagnosed with cancer, treated with curative intent and having completed major treatments (surgery, radiotherapy, chemotherapy) within the last 5 years

Exclusion Criteria:

* Not volunteering to participate in research
* Having a visual, hearing or mental disability
* Agreeing to participate in another psychoeducational program conducted simultaneously with the research
* Inability to communicate in Turkish
* Having previously received training in forgiveness and/or coping with fear of relapse

Primary outcomes:
measure: Heartland Forgiveness Scale
timeFrame: Baseline, 6 th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)
Secondary outcomes:
measure: Brief Symptom Inventory
timeFrame: Baseline, 6th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)
measure: EORTC QLQ-C30 Quality of Life ScaleThe
timeFrame: Baseline, 6th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)
measure: Fear of Cancer Recurrence Inventory
timeFrame: Baseline, 6th week, 1st month follow-up, 3rd month follow-up) (Pre-test-post-test follow-up experimental design)
Other outcomes:
measure: Introductory Information Form
timeFrame: Baseline, 1st month follow-up, 3rd month follow-up (Pre-test-post-test follow-up experimental design)
Locations:
city: Ankara
country: Turkey
facility: Gülhane Health Sciences Institute
state: Keçiören
Study officials:
affiliation: Saglik Bilimleri Universitesi
name: Gamze Sarıkoç, Associate Professor
role: STUDY_DIRECTOR
References: